14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.17 $7.64 Wednesday, 24th Apr 2024 FATE stock ended at $4.30. This is 5.29% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.75% from a day low at $4.17 to a day high of $4.66.
90 days $4.17 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Aug 14, 2023 $3.08 $3.06 $2.93 $3.02 3 651 048
Aug 11, 2023 $3.23 $3.30 $3.08 $3.09 2 828 503
Aug 10, 2023 $3.37 $3.45 $3.21 $3.26 1 812 037
Aug 09, 2023 $3.50 $3.76 $3.34 $3.40 2 800 443
Aug 08, 2023 $3.53 $3.55 $3.46 $3.53 1 805 268
Aug 07, 2023 $3.83 $3.76 $3.48 $3.55 2 048 309
Aug 04, 2023 $3.71 $3.92 $3.71 $3.73 1 585 443
Aug 03, 2023 $3.74 $3.75 $3.61 $3.69 2 054 140
Aug 02, 2023 $3.92 $3.93 $3.73 $3.76 2 226 209
Aug 01, 2023 $4.12 $4.12 $3.93 $3.97 1 595 753
Jul 31, 2023 $4.21 $4.30 $4.08 $4.13 1 513 864
Jul 28, 2023 $4.20 $4.30 $4.17 $4.21 1 377 632
Jul 27, 2023 $4.31 $4.31 $4.08 $4.10 1 847 287
Jul 26, 2023 $4.25 $4.35 $4.21 $4.27 1 552 019
Jul 25, 2023 $4.30 $4.34 $4.24 $4.28 1 231 957
Jul 24, 2023 $4.50 $4.49 $4.28 $4.31 2 150 822
Jul 21, 2023 $4.51 $4.55 $4.38 $4.46 1 315 514
Jul 20, 2023 $4.59 $4.62 $4.43 $4.45 2 171 973
Jul 19, 2023 $4.65 $4.76 $4.58 $4.60 2 275 106
Jul 18, 2023 $4.65 $4.77 $4.56 $4.59 1 372 125
Jul 17, 2023 $4.75 $4.88 $4.65 $4.66 2 130 844
Jul 14, 2023 $4.95 $4.95 $4.70 $4.73 1 253 866
Jul 13, 2023 $4.97 $5.06 $4.90 $4.92 1 034 847
Jul 12, 2023 $4.98 $5.08 $4.83 $4.94 1 718 371
Jul 11, 2023 $5.04 $5.06 $4.84 $4.86 1 204 281
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT